Clinical trial
Reversal of Neuromuscular Blockade During the General Anaesthesia
NCT04048655 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reversal of Neuromuscular Blockade During the General Anaesthesia
- Lead sponsor
- Tampere University Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 8, 2020
- Completion date
- December 31, 2025
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neuromuscular blockade